Tumor necrosis factor is required for RANTES-induced astrocyte monocyte chemoattractant protein-1 production

GLIA

Volumn 43, Issue 2, 2003, Pages 119-127

  Luo, Yi ^a   Berman, Michael A ^a   Abromson Leeman, Sara R ^a   Dorf, Martin E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Chemokines; Inflammation; Neuroimmunology

Indexed keywords

CHEMOKINE; CYTOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; ASTROCYTE; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; INFLAMMATORY DISEASE; MEDIATOR RELEASE; MOUSE; NEWBORN; NONHUMAN; PROTEIN INDUCTION;

ANIMALS; ANTIBODIES; ANTIGENS, CD; ASTROCYTES; CELLS, CULTURED; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; MACROPHAGE INFLAMMATORY PROTEIN-1; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MONOKINES; NUCLEASE PROTECTION ASSAYS; PROTEIN SYNTHESIS INHIBITORS; RANTES; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0042806319     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.10231     Document Type: Article

References (52)

1. Abromson-Leeman S, Maverakis E, Bronson R, Dorf ME. 2001. CD40-mediated activation of T cells accelerates, but is not required for, encephalitogenic potential of myelin basic protein-recognizing T cells in a model of progressive experimental autoimmune encephalomyelitis. Eur J Immunol 31:527-538.
2. Andjelkovic AV, Kerkovich D, Pachter JS. 2000. Monocyte:astrocyte interactions regulate MCP-1 expression in both cell types. J Leukoc Biol 68:545-552.
3. Asensio VC, Campbell IL. 1999. Chemokines in the CNS: pluri-functional mediators in diverse states. Trends Neurosci 22:504-512.
4. Baggiolini M. 1998. Chemokines and leukocyte traffic. Nature 392:565-568.
5. Bakhiet M, Tjemlund A, Mousa A, Gad A, Stromblad S, Kuziel WA, Seiger A, Andersson J. 2001. RANTES promotes growth and survival of human first trimester forebrain astrocytes. Nature Cell Biol 3:150-157.
6. Bezzi P, Domercq M, Brambilla L, Galli R, Schols D, De Clercq E, Vescovi A, Bagetta G, Kollias G, Meldolesi J, Volterra A. 2001. CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat Neurosci 4:702-710.
7. Browning DD, Diehl WC, Hsu MH, Schraufstatter IU, Ye RD. 2000. Autocrine regulation of interleukin-8 production in human monocytes. Am J Physiol Lung Cell Mol Physiol 279:L1129-1136.
8. Bush TG, Puvanachandra N, Horner CH, Polito A, Ostenfeld T, Svendsen CN, Mucke L, Johnson MH, Sofroniew MV. 1999. Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron 23:297-308.
9. Devi S, Laning J, Luo Y, Dorf ME. 1995. Biologic activities of the beta-chemokine TCA3 on neutrophils and macrophages. J Immunol 154:5376-5383.
10. Dong Y, Benveniste EN. 2001. Immune function of astrocytes. Glia 36:180-190.
11. Dorf ME, Berman MA, Tanabe S, Heesen M, Luo Y. 2000. Astrocytes express functional chemokine receptors. J Neuroimmunol 111:109-121.
12. Dorf ME, Fischer FR, Berman MA, Luo Y. 2002. Chemokine interactions with astrocytes. In: Ransohoff RM, Suzuki K, Proudfoot AEI, Hickey WF, Harrison JK, editors. Universes in delicate balance: chemokines and the nervous system. Amsterdam: Elsevier Science. p 257-272.
13. Fife BT, Huffnagle GB, Kuziel WA, Karpus WJ. 2000. CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis. J Exp Med 192:899-905.
14. Fischer FR, Santambrogio L, Luo Y, Berman MA, Hancock WW, Dorf ME. 2000. Modulation of experimental autoimmune encephalomyelitis: effect of altered peptide ligand on chemokine and chemokine receptor expression. J Neuroimmunol 110:195-208.
15. Glabinski AR, Tani M, Tuohy VK, Tuthill RJ, Ransohoff RM. 1995. Central nervous system chemokine mRNA accumulation follows initial leukocyte entry at the onset of acute murine experimental autoimmune encephalomyelitis. Brain Behav Immun 9:315-330.
16. Glabinski AR, Tani M, Strieter RM, Tuohy VK, Ransohoff RM. 1997. Synchronous synthesis of alpha- and beta-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis. Am J Pathol 150:617-630.
17. Glabinski AR, Tuohy VK, Ransohoff RM. 1998. Expression of chemokines RANTES, MIP-1alpha and GRO-alpha correlates with inflammation in acute experimental autoimmune encephalomyelitis. Neuroimmunomodulation 5:166-171.
18. Godiska R, Chantry D, Dietsch GN, Gray PW. 1995. Chemokine expression in murine experimental allergic encephalomyelitis. J Neuroimmunol 58:167-176.
19. Grell M, Douni E, Wajant H, Lohden M, Clauss M, Maxeiner B, Georgopoulos S, Lesslauer W, Kollias G, Pfizenmaier K, et al. 1995. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83:793-802.
20. Han Y, Wang J, Zhou Z, Ransohoff RM. 2000. TGFbeta1 selectively up-regulates CCR1 expression in primary murine astrocytes. Glia 30:1-10.
21. Han Y, He T, Huang DR, Pardo CA, Ransohoff RM. 2001. TNF-alpha mediates SDF-1 alpha-induced NF-kappa B activation and cytotoxic effects in primary astrocytes. J Clin Invest 108:425-435.
22. Hayashi M, Luo Y, Laning J, Strieter RM, Dorf ME. 1995. Production and function of monocyte chemoattractant protein-1 and other beta-chemokines in murine glial cells. J Neuroimmunol 60:143-150.
23. Haydon PG. 2001. GLIA: listening and talking to the synapse. Nat Rev Neurosci 2:185-193.
24. Hofman FM, Hinton DR, Johnson K, Merrill JE. 1989. Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 170:607-612.
25. Huang D, Han Y, Rani MR, Glabinski A, Trebst C, Sorensen T, Tani M, Wang J, Chien P, O'Bryan S, Bielecki B, Zhou ZL, Majumder S, Ransohoff RM. 2000. Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation. Immunol Rev 177:52-67.
26. Huang DR, Wang J, Kivisakk P, Rollins BJ, Ransohoff RM. 2001. Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J Exp Med 193:713-726.
27. Hvas J, McLean C, Justesen J, Kannourakis G, Steinman L, Oksenberg JR, Bernard CC. 1997. Perivascular T cells express the proinflammatory chemokine RANTES mRNA in multiple sclerosis lesions. Scand J Immunol 46:195-203.
28. Izikson L, Klein RS, Charo IF, Weiner HL, Luster AD. 2000. Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J Exp Med 192:1075-1080.
29. Karpus WJ, Lukacs NW, McRae BL, Strieter RM, Kunkel SL, Miller SD. 1995. An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J Immunol 155:5003-5010.
30. Kollias G, Douni E, Kassiotis G, Kontoyiannis D. 1999. On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. Immunol Rev 169:175-194.
31. Kuchroo VK, Martin CA, Greer JM, Ju ST, Sobel RA, Dorf ME. 1993. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J Immunol 151:4371-4382.
32. Luo Y, Laning J, Hayashi M, Hancock PR, Rollins B, Dorf ME. 1994. Serologic analysis of the mouse beta chemokine JE/monocyte chemoattractant protein-1. J Immunol 153:3708-3716.
33. Luo Y, Lloyd C, Gutierrez-Ramos JC, Dorf ME. 1999. Chemokine amplification in mesangial cells. J Immunol 163:3985-3992.
34. Luo Y, Fischer FR, Hancock WW, Dorf ME. 2000. Macrophage inflammatory protein-2 and KC induce chemokine production by mouse astrocytes. J Immunol 165:4015-4023.
35. Luo Y, Berman MA, Zhai Q, Fischer FR, Abromson-Leeman SR, Zhang Y, Kuziel WA, Gerard C, Dorf ME. 2002. RANTES stimulates inflammatory cascades and receptor modulation in murine astrocytes. Glia 39:19-30.
36. McManus C, Berman JW, Brett FM, Staunton H, Farrell M, Brosnan CF. 1998. MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study. J Neuroimmunol 86:20-29.
37. McManus CM, Weidenheim K, Woodman SE, Nunez J, Hesselgesser J, Nath A, Berman JW. 2000. Chemokine and chemokine-receptor expression in human glial elements: induction by the HIV protein, Tat, and chemokine autoregulation. Am J Pathol 156:1441-1453.
38. Miyagishi R, Kikuchi S, Takayama C, Inoue Y, Tashiro K. 1997. Identification of cell types producing RANTES, MIP-1 alpha and MIP-1 beta in rat experimental autoimmune encephalomyelitis by in situ hybridization. J Neuroimmunol 77:17-26.
39. Mueller C, Corazza N, Trachsel-Loseth S, Eugster HP, Buhler-Jungo M, Brunner T, Imboden MA. 1999. Noncleavable transmembrane mouse tumor necrosis factor-alpha (TNFalpha) mediates effects distinct from those of wild-type TNFalpha in vitro and in vivo. J Biol Chem 274:38112-38118.
40. Rottman JB, Slavin AJ, Silva R, Weiner HL, Gerard CG, Hancock WW. 2000. Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent. Eur J Immunol 30:2372-2377.
41. Schall TJ, Bacon K, Toy KJ, Goeddel DV. 1990. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347:669-671.
42. Schuerwegh AJ, Stevens WJ, Bridts CH, De Clerck LS. 2001. Evaluation of monensin and brefeldin A for flow cytometric determination of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha in monocytes. Cytometry 46:172-176.
43. Selmaj K, Raine CS, Cannella B, Brosnan CF. 1991. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 87:949-954.
44. Simpson JE, Newcombe J, Cuzner ML, Woodroofe MN. 1998. Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions. J Neuroimmunol 84:238-249.
45. Solomon KA, Covington MB, DeCicco CP, Newton RC. 1997. The fate of pro-TNF-alpha following inhibition of metalloprotease-dependent processing to soluble TNF-alpha in human monocytes. J Immunol 159:4524-4531.
46. Tanabe S, Heesen M, Berman MA, Fischer MB, Yoshizawa I, Luo Y, Dorf ME. 1997. Murine astrocytes express a functional chemokine receptor. J Neurosci 17:6522-6528.
47. Tani M, Glabinski AR, Tuohy VK, Stoler MH, Estes ML, Ransohoff RM. 1996. In situ hybridization analysis of glial fibrillary acidic protein mRNA reveals evidence of biphasic astrocyte activation during acute experimental autoimmune encephalomyelitis. Am J Pathol 148:889-896.
48. + T cells. Blood 97:1144-1146.
49. Wen DZ, Rowland A, Derynck R. 1989. Expression and secretion of gro/MGSA by stimulated human endothelial cells. EMBO J 8:1761-1766.
50. Woodroofe N, Cross AK, Harkness K, Simpson JE. 1999. The role of chemokines in the pathogenesis of multiple sclerosis. Adv Exp Med Biol 468:135-150.
51. Xu H, Sethi JK, Hotamisligil GS. 1999. Transmembrane tumor necrosis factor (TNF)-alpha inhibits adipocyte differentiation by selectively activating TNF receptor 1. J Biol Chem 274:26287-26295.
52. Zhang Y, Zhai Q, Luo Y, Dorf ME. 2002. RANTES-mediated chemokine transcription in astrocytes involves activation and translocation of p90 ribosomal S6 protein kinase (RSK). J Biol Chem 277:19042-19048.